In this study, we analyzed the risk factors for BCR and lymph node metastasis in patients who underwent RARP using detailed morphological, immunohistochemical, and statistical analyses of surgical specimens. The gene discussed is BCR; the disease is metastatic malignant neoplasm in the lymph nodes.